Enterprise Ireland
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial
Role: collaborator
Combination Plant-Based Protein and Marine-Based Multi-Mineral Supplement and Bone Remodeling in Young Adults
Role: collaborator
Bioavailability of Plant Protein Amino Acids
Role: collaborator
Preliminary Investigation of a Smart Compression Therapy Prototype
Role: collaborator
The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise
Role: collaborator
Evaluating a Digital Intervention for Overactive Bladder
Role: collaborator
Haemodialysis Outcomes & Patient Empowerment Study 02
Role: collaborator
F-Point Validation Study
Role: collaborator
The Role of Milk Derived Peptides on Glycaemic Control
Role: collaborator
All 9 trials loaded